{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:29Z","timestamp":1791639149798,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism is an endocrine pathology that affects calcium metabolism. Patients with primary hyperparathyroidism have high concentrations of serum calcium or high concentrations of parathyroid hormone, or incorrect parathyroid hormone levels for serum calcium values. Primary hyperparathyroidism is due to the presence of an adenoma\/single-gland disease in 80\u201385%. Multiple gland disease or hyperplasia accounts for 10\u201315% of cases of primary hyperparathyroidism. Atypical parathyroid adenoma and parathyroid carcinoma are both responsible for about 1.2\u20131.3% and 1% or less of primary hyperparathyroidism, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study and enrolled 117 patients with primary hyperparathyroidism undergoing minimally invasive parathyroidectomy. Histological and immunohistochemical examination showed that 107 patients (91.5%) were diagnosed with typical adenoma (group A), while 10 patients (8.5%) were diagnosed with atypical parathyroid adenoma (group B). None of the patients were affected by parathyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Significant statistical differences were found in histological and immunohistochemical parameters as pseudocapsular invasion (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), bands of fibrosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), pronounced trabecular growth (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), mitotic rates of &gt;\u20091\/10 high-power fields (HPFs) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), nuclear pleomorphism (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036), thick capsule (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), Ki-67+\u2009&gt;\u20094% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001), galectin-3\u2009+\u2009(\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and protein gene product (PGP) 9.5\u2009+\u2009(\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.038).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Atypical parathyroid adenoma is a tumor that has characteristics both of typical adenoma and parathyroid carcinoma. The diagnosis is reached by excluding with strict methods the presence of malignancy criteria. Atypical parathyroid adenoma compared to typical adenoma showed significant clinical, hematochemical, histological, and immunohistochemical differences. We did not find any disease relapse in the 10 patients with atypical parathyroid adenoma during 60\u2009months of follow-up time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-021-02123-7","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T12:02:42Z","timestamp":1611144162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Atypical parathyroid adenoma: clinical and anatomical pathologic features"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-6841","authenticated-orcid":false,"given":"Alessandro","family":"Galani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Dimko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Baronchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Gheza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"10116","key":"2123_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168\u201378.","journal-title":"Lancet."},{"key":"2123_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2016.10.035","volume":"456","author":"V Vaira","year":"2017","unstructured":"Vaira V, Verdelli C, Forno I, Corbetta S. MicroRNAs in parathyroid physiopathology. Mol Cell Endocrinol. 2017;456:9\u201315.","journal-title":"Mol Cell Endocrinol"},{"issue":"17\u201318","key":"2123_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10354-013-0235-z","volume":"163","author":"RW Gasser","year":"2013","unstructured":"Gasser RW. Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy. Wien Med Wochenschr. 2013;163(17\u201318):397\u2013402.","journal-title":"Wien Med Wochenschr"},{"issue":"11","key":"2123_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","volume":"41","author":"F Saponaro","year":"2018","unstructured":"Saponaro F, Cetani F, Repaci A, et al. Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Investig. 2018;41(11):1339\u201348.","journal-title":"J Endocrinol Investig"},{"issue":"9684","key":"2123_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145\u201358.","journal-title":"Lancet."},{"issue":"4","key":"2123_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.surg.2015.06.022","volume":"158","author":"KL McCoy","year":"2015","unstructured":"McCoy KL, Seethala RR, Armstrong MJ, et al. The clinical importance of parathyroid atypia: is long-term surveillance necessary? Surgery. 2015;158(4):929\u201335.","journal-title":"Surgery."},{"issue":"Suppl 2","key":"2123_CR7","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","volume":"24","author":"RA Delellis","year":"2011","unstructured":"Delellis RA. Parathyroid tumors and related disorders. Mod Pathol. 2011;24(Suppl 2):S78\u201393.","journal-title":"Mod Pathol"},{"key":"2123_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR. AJCC cancer staging manual. 8th ed. Berlin: Spinger; 2017. ISBN: 978-3-319-40617-6","edition":"8"},{"issue":"10","key":"2123_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","volume":"151","author":"SM Wilhelm","year":"2016","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Sol\u00f3rzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE. The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959\u201368. https:\/\/doi.org\/10.1001\/jamasurg.2016.2310.","journal-title":"JAMA Surg"},{"key":"2123_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jocd.2009.03.098","volume":"12","author":"EM Lewiecki","year":"2009","unstructured":"Lewiecki EM, Baim S, Langman CB, Bilezikian JP. The official positions of the International Society for Clinical Densitometry: perceptions and commentary. J Clin Densitom. 2009;12:267.","journal-title":"J Clin Densitom"},{"key":"2123_CR11","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561.","journal-title":"J Clin Endocrinol Metab"},{"key":"2123_CR12","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3580.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2123_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2967\/jnumed.107.040428","volume":"48","author":"WC Lavely","year":"2007","unstructured":"Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Tufano RP, Zeiger MA, Ziessman HA. Comparison of SPECT\/CT, SPECT, and planar imaging with single- and dual-phase (99\u2009m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48(7):1084\u20139.","journal-title":"J Nucl Med"},{"issue":"6","key":"2123_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jcu.20131","volume":"33","author":"H Gilat","year":"2005","unstructured":"Gilat H, Cohen M, Feinmesser R, Benzion J, Shvero J, Segal K, Ulanovsky D, Shpitzer T. Minimally invasive procedure for resection of a parathyroid adenoma: the role of preoperative high-resolution ultrasonography. J Clin Ultrasound. 2005;33(6):283\u20137.","journal-title":"J Clin Ultrasound"},{"issue":"5","key":"2123_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/archsurg.141.5.483","volume":"141","author":"B Chiu","year":"2006","unstructured":"Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg. 2006;141(5):483\u20137 discussion 487-488.","journal-title":"Arch Surg"},{"issue":"5","key":"2123_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00423-009-0510-z","volume":"394","author":"M Barczynski","year":"2009","unstructured":"Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbeck\u2019s Arch Surg. 2009;394(5):843\u20139.","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"4","key":"2123_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.amjsurg.2013.05.012","volume":"207","author":"TS Wang","year":"2014","unstructured":"Wang TS, Pasieka JL, Carty SE. Techniques of parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught. Am J Surg. 2014;207(4):527\u201332.","journal-title":"Am J Surg"},{"issue":"5","key":"2123_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","volume":"38","author":"C Marcocci","year":"2015","unstructured":"Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Investig. 2015;38(5):577\u201393.","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"2123_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4158\/EP14462.DSC","volume":"21","author":"BC Stack Jr","year":"2015","unstructured":"Stack BC Jr, Bimston DN, Bodenner DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: postoperative hypoparathyroidism - definitions and management. Endocr Pract. 2015;21(6):674\u201385.","journal-title":"Endocr Pract"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766\u201372.","journal-title":"Clin Chem"},{"issue":"5","key":"2123_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/bjs.5570","volume":"94","author":"G Ippolito","year":"2007","unstructured":"Ippolito G, Palazzo FF, Sebag F, De Micco C, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94(5):566\u201370.","journal-title":"Br J Surg"},{"issue":"2","key":"2123_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.amjsurg.2010.06.003","volume":"202","author":"P O\u2019Neal","year":"2011","unstructured":"O\u2019Neal P, Mowschenson P, Connolly J, Hasselgren PO. Large parathyroid tumors have an increased risk of atypia and carcinoma. Am J Surg. 2011;202(2):146\u201350.","journal-title":"Am J Surg"},{"issue":"2","key":"2123_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0002-9440(10)64568-3","volume":"157","author":"S Kyt\u00f6l\u00e4","year":"2000","unstructured":"Kyt\u00f6l\u00e4 S, Farnebo F, Obara T, Isola J, Grimelius L, Farnebo LO, Sandelin K, Larsson C. Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol. 2000;157(2):579\u201386.","journal-title":"Am J Pathol"},{"issue":"2","key":"2123_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/cncr.22790","volume":"110","author":"GG Fernandez-Ranvier","year":"2007","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Jensen K, Zarnegar R, Lee J, Kebebew E, Duh QY, Clark OH. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer. 2007;110(2):255\u201364.","journal-title":"Cancer."},{"key":"2123_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fgene.2013.00076","volume":"4","author":"P Imbrici","year":"2013","unstructured":"Imbrici P, Camerino DC, Tricarico D. Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front Genet. 2013;4:76.","journal-title":"Front Genet"},{"issue":"6","key":"2123_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567\u2013610.","journal-title":"Thyroid."},{"issue":"4","key":"2123_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.crad.2009.12.005","volume":"65","author":"CN Patel","year":"2010","unstructured":"Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT\/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65(4):278\u201387.","journal-title":"Clin Radiol"},{"issue":"3","key":"2123_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00268-015-3380-2","volume":"40","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Pradhan R, Kumari N, Krishnani N, Shukla P, Gupta SK, Chand G, Mishra A, Agarwal G, Verma AK, Mishra SK. Molecular characteristics of large parathyroid adenomas. World J Surg. 2016;40(3):607\u201314.","journal-title":"World J Surg"},{"key":"2123_CR29","doi-asserted-by":"publisher","unstructured":"Cetani F, Marcocci C, Torregrossa L, Pardi E. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer. 2019. pii: ERC-19-0135.R2. https:\/\/doi.org\/10.1530\/ERC-19-0135.","DOI":"10.1530\/ERC-19-0135"},{"key":"2123_CR30","doi-asserted-by":"publisher","unstructured":"Delellis RA. Challenging lesions in the differential diagnosis of endocrine tumors: parathyroid carcinoma. Endocr Pathol. 2008;19(4):221\u20135. https:\/\/doi.org\/10.1007\/s12022-008-9050-2 Review. PubMed PMID: 19058032.32].","DOI":"10.1007\/s12022-008-9050-2"},{"issue":"2","key":"2123_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"S Kruijff","year":"2014","unstructured":"Kruijff S, Sidhu SB, Sywak MS, Gill AJ, Delbridge LW. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol. 2014;21(2):426\u201333.","journal-title":"Ann Surg Oncol"},{"key":"2123_CR32","doi-asserted-by":"publisher","first-page":"6065720","DOI":"10.1155\/2018\/6065720","volume":"2018","author":"C Casella","year":"2018","unstructured":"Casella C, Galani A, Totaro L, Ministrini S, Lai S, Dimko M, Portolani N. Total parathyroidectomy with subcutaneous parathyroid forearm autotransplantation in the treatment of secondary hyperparathyroidism: a single-center experience. Int J Endocrinol. 2018;2018:6065720. https:\/\/doi.org\/10.1155\/2018\/6065720 eCollection 2018.","journal-title":"Int J Endocrinol"},{"key":"2123_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fendo.2018.00541","volume":"9","author":"C Casella","year":"2018","unstructured":"Casella C, Ministrini S, Galani A, Mastriale F, Cappelli C, Portolani N. The new TNM staging system for thyroid cancer and the risk of disease downstaging. Front Endocrinol. 2018;9:541. https:\/\/doi.org\/10.3389\/fendo.2018.00541 eCollection 2018.","journal-title":"Front Endocrinol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-021-02123-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T12:04:44Z","timestamp":1611144284000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02123-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02123-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The retrospective observational study was submitted to the Spedali Civili Brescia Ethics Committee. The answer of the Ethics Committee was that according to current Italian Law, the approval of the Ethics Committee for a retrospective observational study is not required. Informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}